Interviews

Bilan du congrès avec Thomas Voit, Président du congrès Myologie 2008 et Directeur scientifique et médical de l'Institut de Myologie (Paris)


Bilan du congrès avec Serge Braun, Directeur scientifique de l'AFM


Christophe Marcelle, France
Intervention : Skeletal muscle morphogenesis and growth. A bird's eye view (Mardi 27 mai)


Shin'ichi Takeda, Japon
Intervention : Characterization of adult progenitor cells in skeletal muscle (Mardi 27 mai)


Krysztof Jagla, France
Intervention : Genetic control of cell fate specification during myogenesis : learning from Drosophila (Mardi 27 mai)


Pascal Maire, France 
Intervention  : Six homoproteins control several steps of skeletal muscle development (Mardi 27 mai)


Romain Gherardi, France 
Intervention  : Muscle satellite cells and endothelial cells : close neighbours and privileged partners (Mardi 27 mai)


Giulio Cossu, Italie
Intervention : Toward the cell therapy for muscle dystrophies (Mardi 27 mai)


Christian Pinset, France
Intervention : Is there a future for muscle repair by cell therapy (Mardi 27 mai)


Marc Peschanski, France
Intervention : Human embryonic stem cells, a dual therapeutic toom fort monogenic diseases and senescence (Mardi 27 mai)


Kenneth Chien, Etats-Unis
Intervention : How to make a herat : multipotent cardiovascular progenitors in development and disease (Mercredi 28 mai)


Denis Duboc, France
Intervention : Perindopril treatment in DMD and prevention of sudden death in laminopathies (Mercredi 28 mai)


Michel Pucéat, France
Intervention : Cardiac commitment of human embryonic stem cells : towards the generation of cardiac progenitors for cell therapy of heart failure ( Mercredi 28 mai)


Gisèle Bonne, France
Intervention : Animal models in laminopathies (Mercredi 28 mai)


Christelle Monville, France
Intervention : An in vitro beating heart model for functional assessment of pharmacological compounds and cell therapy (Mercredi 28 mai)


Patricia Lemarchand, France
Intervention : Cardiac cell therapy : clinical trials (Mercredi 28 mai)


Jean-Thomas Vilquin, France (Mercredi 28 mai)
Intervention : Myoblast transplantation from human embryonic stem cells and cardiac regeneration (Mercredi 28 mai)


Nicolas Lévy, France
Intervention : Laminopathies in human and mouse : from gene defects to therapies (Mercredi 28 mai)


Yvan Torrente, Italie
Intervention : Autologous transplantation of engineered muscle derived CD133+ stem cells (Mercredi 28 mai)


Philippe Moullier, France
Intervention : Adeno-associated viral vector genomes as episomal chromatin in primate skeletal muscle (Mercredi 28 mai)


Steve Wilton, Australie
Intervention : Splice intervention therapies for muscle diseases (Mercredi 28 mai)


Martine Barkats, France
Intervention : AAV-mediated gene transfer in the central nervous system of a feline model of SMA (Jeudi 29 mai)


George Dickson, Grande-Bretagne
Intervention : Antisense and RNAi technologies : from natural phenomena to new therapeutics (Vendredi 30 mai)


Luis Garcia, France
Intervention : Muscle function recovery in dystrophic dog after exon skipping gene therapy (Vendredi 30 mai)


Judith van Deutekom, Pays-Bas
Intervention : Pre-clinical and clinical development of 20MePS antisense oligonucleotides for DMD (Vendredi 30 mai)


Daniel Schümperli, Suisse
Intervention : Correction of SMN2 splicing by a bifunctional U7 snRNA complements (Vendredi 30 mai)


Christophe Béroud, France
Intervention : Knowledge bases to facilitate theraputic approaches (Vendredi 30 mai)


Alexandra Belayew, Belgique
Intervention : Homeodomain transcription factors DUX4, PITX1 and DUX4C : new actors in the molecular mechanism of FSHD (Vendredi 30 mai) 


Carole Bérard, France
Intervention : The Motor Function Measure, an outcome measure adapted to most neuromuscular diseases (Vendredi 30 mai)


François Boyer, France
Intervention : Conceptual approaches of the quality of life measurements used in medicine (Vendredi 30 mai)